Inventor
POPOVICI-MULLER JANETA
US46 patents
⚠️ This page may combine multiple inventors who share the name “POPOVICI-MULLER JANETA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AGIOS PHARMACEUTICALS INC
25 patentsUS9474779B2Oct 25, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC36 citations97
US9579324B2Feb 28, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC22 citations94
US9512107B2Dec 6, 2016
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC25 citations94
US9850277B2Dec 26, 2017
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC22 citations93
US9732062B2Aug 15, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC18 citations92
US9656999B2May 23, 2017
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC16 citations92
US10294215B2May 21, 2019
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC6 citations84
US10172864B2Jan 8, 2019
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC8 citations84
US9458132B2Oct 4, 2016
Therapeutic compounds and compositions and their use as PKM2 modulators
AGIOS PHARMACEUTICALS INC18 citations84
US11505538B1Nov 22, 2022
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations73
US10028961B2Jul 24, 2018
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC4 citations73
US10717764B2Jul 21, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC1 citations72
US10640534B2May 5, 2020
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC2 citations72
US10376510B2Aug 13, 2019
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
AGIOS PHARMACEUTICALS INC3 citations72
US11524960B2Dec 13, 2022
Heterobicyclic inhibitors of MAT2A and methods of use for treating cancer
AGIOS PHARMACEUTICALS INC2 citations65
US11021515B2Jun 1, 2021
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations62
US10946023B2Mar 16, 2021
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations62
US10202339B2Feb 12, 2019
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC1 citations62
US10011574B2Jul 3, 2018
Glutaminase inhibitors and method of use
AGIOS PHARMACEUTICALS INC1 citations62
US10689375B2Jun 23, 2020
Compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations52
US10414740B2Sep 17, 2019
Glutaminase inhibitors and method of use
AGIOS PHARMACEUTICALS INC0 citations52
US10087172B2Oct 2, 2018
Compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations52
US10689414B2Jun 23, 2020
Therapeutically active compounds and their methods of use
AGIOS PHARMACEUTICALS INC0 citations51
US9856279B2Jan 2, 2018
Therapeutically active compositions and their methods of use
AGIOS PHARMACEUTICALS INC1 citations51
US9365545B2Jun 14, 2016
Therapeutic compounds and compositions
AGIOS PHARMACEUTICALS INC0 citations51
SCHERING CORP
10 patentsUS7524842B2Apr 28, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP19 citations92
US7504424B2Mar 17, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP24 citations92
US7488745B2Feb 10, 2009
Compounds for the treatment of inflammatory disorders
SCHERING CORP23 citations92
US7687527B2Mar 30, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP8 citations84
US7879890B2Feb 1, 2011
Compounds for the treatment of inflammatory disorders
SCHERING CORP6 citations73
US7772263B2Aug 10, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP7 citations73
US7196111B2Mar 27, 2007
Pyrazolo[1,5a]pyrimidine compounds as antiviral agents
SCHERING CORP8 citations72
US7683088B2Mar 23, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP1 citations62
US7652020B2Jan 26, 2010
Compounds for the treatment of inflammatory disorders
SCHERING CORP5 citations62
US7511063B2Mar 31, 2009
High affinity quinoline-based kinase ligands
SCHERING CORP0 citations39
SERVIER PHARMACEUTICALS LLC
3 patentsUS12433895B2Oct 7, 2025
Therapeutically active compounds and their methods of use
SERVIER PHARMACEUTICALS LLC0 citations62
US11667673B2Jun 6, 2023
Therapeutically active compounds and their methods of use
SERVIER PHARMACEUTICALS LLC0 citations62
US11844758B2Dec 19, 2023
Therapeutically active compounds and their methods of use
SERVIER PHARMACEUTICALS LLC1 citations61